Zurueck zur Suche

Reporte zur Charge UT7743CA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

23Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 4 IL 3 WI 3 CT 3 MI 2 DE 2 VA 1 OH 1 MA 1 ND 1

VAERS 2576577

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

kritisch
Staat
MI
Alter
72,0
Geschlecht
F
Eingang
06.02.2023
Impfdatum
24.10.2022
Beginn
24.01.2023
Tage bis Beginn
92,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 COVID-19 pneumonia Dyspnoea exertional Hypovolaemic shock Magnetic resonance imaging heart Physical deconditioning Septic shock Tachycardia

Symptomtext

Admission Date: 1/24/2023 Discharge Date: 2/3/23 PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 73 y.o. woman s/p right lung transplant 8/3/2015 for RA related pulmonary fibrosis, admitted 1/24/23 due to COVID-19 pneumonia and shock related to hypovolemia. Receiving decadrone and remdesivir. Now with persistent dyspnea, tachycardia on exertion. Cardiac MRI repeated while here, structural heart stated stable and no intervention at this time. O2 was able to be weaned to room air at rest and 2 liters with activity, She continues to have DOE and tachycardia with exertion (had for past year +) - suspect this is due to multifactorial etiology: deconditioning, underlying heart disease (valvular), single lung, recent COVID. PT recommended acute rehab, palliative had goals of care discussion - hospice vs rehab - they wanted to try a week of rehab then go home and re-assess hospice vs continued palliative care. Her insurance denied rehab - family and patient wanted to go home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Septic shock
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Right Lung Transplant (HCC) Immune suppressed state, need for antimicrobial prophylaxis (HCC) Bronchiolitis obliterans syndrome, grade 0P (HCC) Frequent UTI Depression Anxiety Osteoporosis Hypothyroidism Rheumatoid arthritis (HCC) Shortness of breath Compression fx, thoracic spine, chronic back pain Transverse myelitis (HCC) Gastroparesis Encounter for long-term (current) drug use CMV (cytomegalovirus) infection (HCC) Sensorineural hearing loss of left ear Long term current use of systemic steroids Hypercholesterolemia Acute rejection of lung transplant (HCC) Antibody mediated rejection of lung transplant (HCC) Lumbar stenosis Cervical spondylosis with myelopathy Venous stasis Calcification of abdominal aorta - without AAA - (HCC) Steroid-induced adrenal suppression (HCC) Hoarseness of voice Squamous cell skin cancer Tracheobronchitis Acute renal failure superimposed on stage 3 chronic kidney disease (HCC) Nonrheumatic tricuspid valve regurgitation Nonrheumatic mitral valve regurgitation Other constipation Counseling regarding goals of care Need for assistance with personal care Osteonecrosis of jaw due to drug (HCC) Opioid contract exists Chronic left shoulder pain Iron deficiency anemia COVID-19 Shock (HCC) Acute respiratory failure with hypoxia (HCC) Noninfected skin tear of left leg
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet acyclovir (ZOVIRAX) 200 MG capsule azithromycin (ZITHROMAX) 250 MG tablet budesonide/formoterol (SYMBICORT) 160-4.5 MCG/ACT inhaler calcium citrate-vitamin D (CITRACAL) 315-250 MG-UNIT tablet escitalopr
Allergien
LeflunomideHallucinations, Hives, Confusion, Rash NsaidsOther Adhesive Tape Albuterol Alvesco [Ciclesonide]Hallucinations Arava [Leflunomide]Rash Arformoterol AtenololOther Brovana [Arformoterol Tartrate] BupivacaineConfusion Hydroxychloroquine Macrodantin [Nitrofurantoin] NaproxenHives, Diarrhea Nitrofurantoin OmnicefRash Omnicef [Cefdinir] ParoxetineDiarrhea, Rash Plaquenil [Hydroxychloroquine Sulfate]Hives, Rash Pyridium [Barbiturates] Pyridium [Phenazopyridine]Difficulty concentrating Sulfadiazine
Vorherige Impfungen
-

VAERS 2490222

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

kritisch
Staat
IL
Alter
77,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
21.10.2022
Beginn
26.10.2022
Tage bis Beginn
5,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal Chest discomfort Cough Dizziness Dyspnoea Electrocardiogram ST-T segment abnormal Feeling abnormal Pulmonary embolism Vomiting

Symptomtext

Received both vaccines on Friday 10/21/22, felt bad on Saturday shortness of breath and cough with worsening symptoms with exertion and felt dizzy. O2 saturations 84% and improved to 88% after 2L of nasal cannula at urgent care. In the ER, patient's O2 saturations was 84% on room air there, placed on 3L O2 nasal cannula and improved to 95%. Denies headache or focal neurological symptoms but stated that she sees halos. No chest pain but a little tightness. No palpitation. No abdominal pain little nausea. Yesterday she vomited after coughing fits. No history of heart problems. Former smoker but no history of asthma or COPD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
CTA- positive for large saddle pulmonary embolism with extension into bilateral lobar and segmental branches of pulmonary arteries with evidence of right ventricular strain.
Aktuelle Erkrankungen
None
Vorgeschichte
Colon polyps and runny nose listed as past medical history
Andere Medikamente
Fluticasone propionate 50 mcg/act nasal spray 2 sprays by nasal route daily.
Allergien
Penicillin- rash; sulfa antibiotics- rash
Vorherige Impfungen
-

VAERS 2591816

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

moderat
Staat
MI
Alter
74,0
Geschlecht
M
Eingang
06.03.2023
Impfdatum
27.10.2022
Beginn
23.02.2023
Tage bis Beginn
119,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Asthenia Blood creatinine increased COVID-19 Chronic kidney disease Condition aggravated Constipation Cough Fall Laboratory test normal Malaise Pain Pyrexia Renal impairment SARS-CoV-2 test positive Ultrasound kidney abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/21/2023 Discharge Date: 2/27/23 PRESENTING PROBLEM: Weakness Fall, initial encounter Chronic kidney disease, unspecified CKD stage COVID COVID-19 HOSPITAL COURSE: Patient is a 74-year-old male with a past medical history of ankylosing spondylitis, chronic pain, hypertension, prostate cancer, decubitus ulcer stage IV, diabetes mellitus type 2 and dyslipidemia who presented with a chief complaint of fever, recent falls with a positive COVID test at home. Patient was feeling ill 2 days prior to admission with a temperature up to 103?. He recently had been weaning off of gabapentin and on to Lyrica per his nephrologist an outpatient PCP. His pain had increased with these adjustments. He had been started on Norco. He also had been noting constipation. He already was taking tramadol and p.r.n. morphine, but had significant side effects of nausea from his morphine and only took it for breakthrough pain. He had fallen multiple times prior to admission. His daughter noted he was 88% on room air on a home monitor. He was afebrile. His creatinine was elevated from baseline with AKI on CKD stage IV. Labs were otherwise stable. He was admitted to the hospitalist service for COVID-19 infection and generalized weakness with AKI. He was initially treated with gentle fluids without improvement of his kidney function. Renal ultrasound showed no obstruction, but showed bilateral medical renal disease. He was continued on fluids with eventual improvement of his kidney function towards his baseline. Nephrology was consulted and recommended continuing fluids and adding sodium bicarb. In regards to COVID-19, he required up to 3 L nasal cannul and received 5 days of Decadron therapy while inpatient, discharged on room air with mild dry cough. Palliative care was consulted to help with adjustments in his pain medication, His gabapentin was weaned down with plans to completely replace with Lyrica by March 3rd with prescription given on discharge. Final pain plan includes intermittent norco with low dose oxycodone for severe pain available, due to kidney dysfunction morphine was discontinued along with tramadol. PT/OT recommended subacute rehab but patient improved enough during stay to qualify for HHC for PT/OT, and RN for wound care. DC in stable condition on 2/27.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
09/30/20122- Pressure injury of sacral region, stage 4 - Primary
Vorgeschichte
AS (ankylosing spondylitis) Encounter for long-term (current) use of other medications Pressure injury of sacral region, stage 4 Osteomyelitis CKD III Wound infection Constipation Multifocal pneumonia
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet allopurinol (ZYLOPRIM) 300 MG tablet amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG enteric coated tablet azithromycin (ZITHROMAX) 500 MG tablet benzonatate (TESSALON) 100 MG capsule cefuroxime (CEFTIN)
Allergien
DemerolNausea Only
Vorherige Impfungen
-

VAERS 2485172

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

moderat
Staat
WI
Alter
65,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain Pain in extremity Periarthritis X-ray limb

Symptomtext

Patient reported having pain in arm starting the night of receiving the vaccinations. She reports pain 7/10 with limited range of motion. Pain is dull at rest and sharp with any kind of movement. Unable to lift arm above head. She tried Tylenol with minimal relief. She also tried home exercises with minimal increase of range of motion. She returned to clinic 10 days post injections for evaluation. She was diagnosed with frozen shoulder related to vaccine injection. She was order a medrol dose pak and a shoulder xray. She will call our office next week with an update on her symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Shoulder xray performed on 10/21/22.
Aktuelle Erkrankungen
none
Vorgeschichte
Pre-diabetes, GERD
Andere Medikamente
Vitamin D: 2,000 iu daily, probiotic daily
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 2507184

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

mild
Staat
IL
Alter
68,0
Geschlecht
F
Eingang
14.11.2022
Impfdatum
08.11.2022
Beginn
09.11.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Rash erythematous

Symptomtext

RED RASH ALONG BICEPT MEASURING ~8"X4"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2496751

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7743CA

mild
Staat
IL
Alter
35,0
Geschlecht
F
Eingang
02.11.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Immediate post-injection reaction Injection site erythema Injection site pruritus Injection site reaction Injection site swelling

Symptomtext

Colleague states that immediately after the injection she felt a little reaction as the needle was pulled out and it immediately started itching. Area was swollen next day like a "turtle shell" in the area. Colleague marked arm to observe for redness growth, but area did not get bigger. States she has received the flu vaccine annually since 2004 with no history of reaction. Was seen in Emergency Room. Took Benadryl and Pepcid for a few days and site reaction eventually resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2696294

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
VA
Alter
66,0
Geschlecht
F
Eingang
16.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

expired FLUZONE HIGH DOSE was accidentally administered to a patient (with no adverse event); Initial information received on 04-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 66 years old female patient who received expired Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent] accidentally (with no adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Oct-2023, the patient received expired dose of 0.7 ml suspect Influenza Quadrival A-B High Dose Hv Vaccine (strength, formulation and expiry date : unknown, lot UT7743CA) via intramuscular route in the left deltoid as immunization (expired product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644000

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
WI
Alter
72,0
Geschlecht
F
Eingang
12.06.2023
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No adverse events noted. Documentation of COVID vaccine given in error. Per Immunization Registry, patient received a dose of Pfizer Bivalent on 10/12/22 at Pharmacy, was then give a dose of Pfizer bivalent on 10/17/22 at 9:11AM at facility. 10/12/22 Pfizer was reconciled into patient's EMR on 10/17/22 at 3;09pm. This was identified by report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
hypertension, HYPTHYROIDISM, DIALATED PANCREATIC DUCT, ARTHRITIS, SCIATICA, CHRONIC BACK PAIN, DEPRESSION
Andere Medikamente
clonazePAM (KlonoPIN) 1 MG tablet Take 1 tablet by mouth 2 times daily as needed. losartan-hydrochlorothiazide (HYZAAR) 100-12.5 MG per tablet Take 1 tablet by mouth daily. levothyroxine 88 MCG tablet Take 1 tablet by mouth daily. amLO
Allergien
TRAZODONE
Vorherige Impfungen
-

VAERS 2525563

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
NY
Alter
64,0
Geschlecht
F
Eingang
07.12.2022
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Incorrect dose administered No adverse event Wrong product administered

Symptomtext

A flu vaccine, and Td vaccine were ordered to be performed. In error, two flu vaccines were administered. One high dose, and one normal dose. The Td vaccine was not administered. The patient did not have any adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Acute URI, 11/16/22
Vorgeschichte
Osteoporosis, Diabetes Type II, Hypertension, Hyperlipidemia
Andere Medikamente
Alendronate, Anastrozole, Metformin, Fluoxetine, Amlodipine, Atorvastatin
Allergien
Clindamycin, Penicillin, Sulfamethoxazole, Trimethoprim
Vorherige Impfungen
-

VAERS 2520876

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
-
Alter
78,0
Geschlecht
M
Eingang
01.12.2022
Impfdatum
29.11.2022
Beginn
29.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient received a high dose flu vaccine in error as he had already received a flu vaccine on 10/13/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2517854

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
WI
Alter
72,0
Geschlecht
M
Eingang
28.11.2022
Impfdatum
18.11.2022
Beginn
18.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient was given a high dose flu vaccine today at appointment. Records updated in patient's chart after the vaccine was given and showed that patient received a flu vaccine in October 2022. Writer asked patient and he has no memory of getting a flu vaccine in 2022;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2517844

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
-
Alter
60,0
Geschlecht
F
Eingang
28.11.2022
Impfdatum
28.10.2022
Beginn
01.11.2022
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is 60 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. I

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2517517

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
CT
Alter
72,0
Geschlecht
F
Eingang
27.11.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Vaccine vial was punctured on Friday 11/18/22 at approximately 10am and 6 doses drawn up into syringes. These syringes were stored at room temperature. Dose administered to the patient on 11/21/22 was from a syringe that had been drawn up on Friday 11/18 and stored at room temp. Pfizer contacted for stability information, which they did not have for these storage conditions. Patient is being contacted for re-vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
pre-diabetes osteopenia osteoarthritis hyperlipidemia
Andere Medikamente
Fosamax Ascorbic Acid Atorvastatin calcium vitamin d docusate escitalopram fexofenadine MVI Psyllium
Allergien
NKA
Vorherige Impfungen
-

VAERS 2517509

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
CT
Alter
80,0
Geschlecht
M
Eingang
27.11.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product storage error

Symptomtext

Vaccine vial was punctured on Friday 11/18/22 at approximately 10am and 6 doses drawn up into syringes. These syringes were stored at room temperature. Dose administered to the patient on 11/21/22 was from a syringe that had been drawn up on Friday 11/18 and stored at room temp. Pfizer contacted for stability information, which they did not have for these storage conditions. Patient is being contacted for re-vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension Diabetes Gout CKD CHF CAD
Andere Medikamente
Aspirin Carvedilol Colchicine Furosemide Humalog Levemir Losartan Toprol XL Nitrostat Rosuvastatin
Allergien
NKA
Vorherige Impfungen
-

VAERS 2512958

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
NY
Alter
84,0
Geschlecht
F
Eingang
21.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine had a low temp excusion. Was revaccinated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2511665

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
OH
Alter
64,0
Geschlecht
M
Eingang
18.11.2022
Impfdatum
18.11.2022
Beginn
18.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Client's power of attorney (brother) stated he was 65 years old and high dose influenza was given, but client's date of birth is incorrect which would make him 64 years old. No adverse effect.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Downs Syndrome
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2509495

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
MA
Alter
64,0
Geschlecht
F
Eingang
16.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given a high dose prior to eligibility. Patient was contacted the following morning to be made aware of the error and as of 11/16/22 @ 10:45 AM she did not have any adverse effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2508414

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
CT
Alter
87,0
Geschlecht
F
Eingang
15.11.2022
Impfdatum
10.11.2022
Beginn
10.11.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event Vaccination error

Symptomtext

Patient Asked to receive her Flu Vaccine, since her Husband was getting one at same visit. I had checked the system quickly and had not noted Flu Vaccine had been administered 9/9/2022. I administered the Vaccine. Then noted that provider had ordered a BiValent COVID Booster to be given. I administered COVID Booster as ordered. When I went to Barcode the immunizations, I found that patient had had High Dose Flu Vaccine 9/9/2022. Patient tolerated Both Vaccines well and waited in Waiting room 15 minutes before going home. I informed APRN and Dr. of vaccine error. I was instructed by both providers to notify the patient. I called patient at her home and notified her. She stated that she felt fine and experienced no adverse effects. Patient instructed to notify our office with any problems or concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None noted
Vorgeschichte
-
Andere Medikamente
None
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2507318

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
NY
Alter
76,0
Geschlecht
M
Eingang
14.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE HAD LOW TEMPERATURE EXCURSION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2507313

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
NY
Alter
68,0
Geschlecht
F
Eingang
14.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE HAD LOW TEMPERATURE EXCURSION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501929

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
ND
Alter
64,0
Geschlecht
M
Eingang
08.11.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
on O2
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485003

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
DE
Alter
59,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

received a FLUZONE HD QIV in error, due to patients age with no reported adverse event; Initial information received on 13-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 59 years old female patient who received an influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] in error, due to patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect influenza quadrival A-B high dose HV vaccine (Lot Number:UT7743CA,Expiration Date :30-06-2023) reported via unknown route in unknown administration site for prophylactic vaccination in error, due to patient age with no reported adverse event (product administered to patient of inappropriate age) (unknown latency). Action taken: not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01320915:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483768

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7743CA

gering
Staat
DE
Alter
59,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
13.10.2022
Beginn
13.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

59 years old patient who was accidentally administered a high dose flu shot instead of a normal flu shot, with no reported adverse event; 59 years old patient who was accidentally administered a high dose flu shot instead of a normal flu shot, with no reported adverse event; Initial information received on 13-Oct-2022 regarding an unsolicited valid non-serious case from a consumer/non-hcp. This case involves a 59 years old female patient who was accidentally administered influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] instead of a normal flu shot (INFLUENZA VACCINE), with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 13-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at a dose of 0.5 ml (lot UT7743CA, expiry date: 30-Jun-2023) via intramuscular route in the left arm for immunisation. On 13-Oct-2022, 59 years old patient administered high dose flu shot instead of a normal flu shot, with no reported adverse event (product administered to patient of inappropriate age, wrong product administered, latency: same day). Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-